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Abstract
Innovative strategies have become necessary in the treatment of patients diagnosed with sexually
transmitted infections (STIs) and their partners due to increasing rates of infection, transmission,
and reinfection. Expedited Partner Therapy (EPT) is an evidence-based approach for providers to
improve partner treatment and decrease reinfection rates in patients with certain STIs. However,
state-based legislation governs practice implementation and EPT remains prohibited in Kentucky
(KY) despite Centers for Disease Control and Prevention (CDC) endorsement. Delay in policy
change presents increased risk for reinfection and continued transmission in KY. John Kingdon’s
Multiple Streams framework (2003) was used to analyze EPT policy in the state of KY as a
foundational step toward regulation amendment. Advocacy by increasing provider, lobbyist, and
legislative awareness and support was also completed. Interventions included a poster
presentation, white paper formulation and distribution, and communication with key legislators.
Impact was measured through survey collection assessing agreement variables among 80 KY
advanced practice registered nurses (APRNs). 94% of respondents agreed that EPT is a
beneficial treatment strategy and 93.7% indicated support in the advancement of EPT policy.
This project provides the groundwork for future advocacy efforts for EPT legalization in KY.

Keywords: Expedited partner therapy; sexually transmitted disease; sexually transmitted
infection; health policy; legislative advocacy; advanced practice registered nurse
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Expedited Partner Therapy: Advancing Health Policy in Kentucky
The dramatic increase in the incidence of many sexually transmitted infections (STIs) in
the past decade demands attention from healthcare practice and policy. According to the Centers
for Disease Control and Prevention (CDC), Chlamydia trachomatis infection continues to be the
most common notifiable condition in the U.S. National surveillance data reflects over 1.7 million
reported cases of chlamydia in 2017, accounting for a 6.9% increase over the previous year
(CDC, 2018a). This rising trend is alarmingly consistent for many STIs, including those caused
by Neisseria gonorrhoeae and Trichomonas vaginalis (Ault, 2018). The state of Kentucky (KY)
is not exempt from high STI transmission rates, with a reported 18,286 cases of chlamydia and
5,812 cases of gonorrhea in 2016 (CDC, 2017). While these infections affect all genders, races,
and socioeconomic groups in KY, incidence is higher in females, non-Hispanic blacks, and those
aged 15-24 years (CDC, 2017). Because it is suspected that many more cases go undiagnosed
and unreported, current medical practice recommends antibiotic therapy for all partners sexually
exposed to the infected index case, regardless of the diagnostic testing result, in an effort to
prevent morbidity in the partner(s) and further transmission (Hopson & Opiola McCauley, 2017).
The related risks for long-term health complications of STI contraction are widely
established, including the link to pelvic inflammatory disease (PID), chronic abdominal pain,
human immunodeficiency virus (HIV), reproductive system cancers, epididymitis, and infertility.
In response to this epidemic and its related health concerns, the Office of Disease Prevention and
Health Promotion (ODPHP) initiative Healthy People 2020 has made STI prevention a focus in
the improvement of national public health, with 18 specific goals relating to improved screening
and prevention processes. This includes the need for providers to “address system-level barriers
to timely treatment of partners of persons infected with [STIs], including the implementation of
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expedited partner therapy for the treatment of chlamydial and gonorrheal infections” (ODPHP,
2017, para. 10). Expedited Partner Therapy (EPT) emerged in 2006 as a CDC-endorsed,
evidence-based practice to increase treatment for certain STIs in an effort to reduce transmission
and reinfection rates (CDC, 2006). EPT allows clinicians to provide STI-diagnosed patients with
medication or a prescription to deliver to their partner(s) as treatment for exposure. This
eliminates the requirement for in-person medical evaluation of the partner and expedites the
treatment process. In contrast, standard practice has relied on either the patient or the provider to
notify the partner(s) of their exposure to disease and initiate an office visit for treatment. This
standard has been inadequate in preventing spread of infection. The CDC reports that studied
health departments made attempts to contact only 12-17% of partners for patients diagnosed with
chlamydia and/or gonorrhea (2006). Evidence from multiple studies has shown that EPT is an
effective and beneficial strategy option for those patients with limited access to care or those
who are at risk for loss to follow up (CDC, 2006).
Due to the unconventional practice of treating individuals without a physical
examination, utilization of EPT is governed by individual, state-based regulations. Those states
with large, urban populations became the first to adopt the practice in order to maximize
treatment for exposed partners with limited access to healthcare. Since CDC endorsement, nearly
all states have updated their policies to authorize provider use of EPT in the clinical setting.
While it is currently legal and utilized in 48 states, EPT remains prohibited in KY (illustrated in
Figure 1) (CDC, 2018b). Delay in policy change poses a concern for continued spread of
infection in at-risk KY populations as partners of patients with diagnosed STIs remain untreated.
Those with low socioeconomic status, low health literacy, and decreased access to healthcare are
disproportionately at risk for complications related to STIs, making this a clear issue of health
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equity (CDC, 2015). When evaluating strategies for decreasing transmission, EPT addresses
these factors by increasing treatment availability, decreasing cost to both the state healthcare
system and the patient, and addressing personal behavior by mitigating risk for reinfection. The
lack of EPT legalization in KY state policy can be attributed to many internal and external
factors. All causative elements in this setting are important to address as delay in policy change
poses a concern for continued spread of infection in at-risk populations in KY as partners of
patients with diagnosed STIs continue to remain untreated.

Figure 1. State-based legal status of Expedited Partner Therapy.
Purpose
In light of the above-identified findings, the purpose of this project was to analyze the
current legislative environment for EPT and advocate for the advancement of EPT in KY. For
EPT to be integrated as a legal practice, the current prohibitory KY state Department of Public
Health (DPH) regulation “902 KAR 2:080. Sexually transmitted diseases” would need to be
amended (Kentucky Legislative Research Committee, 2007). The specific aim of this project was
to provide the groundwork for future advocacy efforts for EPT legalization in KY.
Literature Review
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A three-purpose strategy was utilized in reviewing the current evidence supporting a
policy change for EPT in KY. Evaluation included efficacy of EPT itself, as well as current
provider knowledge and implementation in states where the practice is legal and utilized.
Reviewed publications encompassed the original randomized controlled trials (RCTs) which
evaluated EPT as an evidence-based strategy in clinical practice. An initial entry revealed a total
of 308 potentially pertinent articles. Quantitative studies were preferred in literature evaluation,
though several qualitative studies were included for their specific and comprehensive insight into
the topic area.
After further quality assessment, which refined index terms and limited research study
inclusion to those which were published and peer-reviewed, a final pool of 18 literary sources
was selected for review. This pool included one systematic review, 14 quantitative and
qualitative studies, one professional committee opinion report, and two national and state-level
practice guidelines. The Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) rating scale
was utilized to evaluate the strength and quality of evidence in the literature. Evidence descends
in rating (I-V) from experimental study/RCT or meta-analysis of RCT (level I), through opinions
of individual experts based on non-research evidence (level V) (Dang & Dearholt, 2018). For
this review, levels of evidence ranged from I to V, with the majority of studies being categorized
as level II (quasi-experimental studies) and level III (nonexperimental studies). A hierarchal
table of evidence of included studies was constructed to portray evidence (Appendix A).
Practice Efficacy
Official guidelines on EPT practice were released by the CDC in 2006 after results from
several RCTs showed increased antibiotic delivery along with equivalent or decreased
reinfection rates of chlamydia and gonorrhea for patients and their partners (Schillinger et al.,
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2003). In a study by Golden et al. (2005), 2,751 subjects diagnosed with chlamydia and/or
gonorrhea were randomly allocated into EPT (N = 931) or standard partner management (N =
929) to determine impact on recurrent infection. A lower rate of recurrence was found in the EPT
group for both chlamydia (OR 0.82, 95% CI 0.62-1.07, p = 0.17) and gonorrhea (OR 0.32, 95%
CI 0.13-0.77, p <0.01). In a systematic review by Trelle, Shang, Nartey, Cassell, and Low
(2007), the efficacy of partner notification was evaluated. EPT (defined as Patient-Delivered
Partner Therapy [PDPT] in this study) was appraised as a method of improvement in patient
referral and reinfection rates. Five of the six trials reflected a reduced risk of persistent or
recurrent infection in patients with chlamydia or gonorrhea in the PDPT intervention group
(summary risk ratio 0.73, 95% confidence interval 0.57 to 0.93) (Trelle et al., 2007). RCTs
which evaluated EPT had strength in large sample sizes and achieved statistical power. Presence
of infection was assessed using valid laboratory urine and swab culture testing which have high
reliability rates (Trelle et al., 2007). However, loss to follow up may have affected internal
reliability and EPT adherence measures were subject to patient report.
Provider Knowledge
Corresponding themes emerged from reviewing literature pertaining to provider
knowledge, attitudes, and implementation in practice. Provider knowledge impacts
implementation of EPT as a treatment strategy. Several different medical specialties were
evaluated, including family practice, gynecology, pediatrics, medical directors, and pharmacy.
Methods for assessing knowledge were generally survey or interview-based, cross-sectional
designs which used random or purposeful sampling techniques (Rosenfeld et al., 2015; Lee et al.,
2014). In one review, only 20% of surveyed providers (n = 195) reported a history of using EPT,
and the majority of this sample group were unaware of or misguided on the legal status of the
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practice in their state (Lee et al., 2014). Even in samples reporting familiarity with the therapy,
providers often mislabeled or misinterpreted the definition of EPT along with its scope and uses
(Hsii, Hillard, Yen, & Golden, 2012; Introcaso et al., 2013; Lee et al., 2014). Studies showed
EPT was not a strategy discussed routinely in formal didactic courses, which may partially
account for the lack of knowledge surrounding the practice. Providers reported the majority of
knowledge on this topic was gained from continuing education, conferences, or direct patient
care with faculty preceptor (Hsii et al., 2012; Rosenfeld et al., 2015). When knowledgeable on
the practice, the majority of providers participating in EPT report favorability towards the
treatment strategy and agree the therapy has extended public health benefits (Hsii et al., 2012;
Golden et al., 2015).
Policy in Implementation
Policy was a central theme in the assessment of EPT practice, and all studies found a
general lack of provider and administrator fluency in both state and facility-based policies
regarding the use of EPT (Hsii et al. 2012; Introcaso et al., 2013; Rosenfeld et al., 2015). Lack of
regulations endorsing EPT as a treatment practice is the most commonly cited barrier in the
literature (Hodge, Pulver, Hogben, Bhattacharya, & Brown, 2008). Alternatively, research has
associated a formal written policy permitting EPT with a higher rate of provider use (Hodge et
al., 2008; Hsii et al., 2012; Owusu-Edusei Jr. et al., 2017). Providers who practiced in an
organization where facility protocols included EPT as a treatment option were more likely to
implement the therapy in their practice (Schillinger, Gorwitz, Rietmeijer, & Golden, 2016).
These findings reflect a need for updated and explicit state health policy to support the successful
implementation of EPT.
Theoretical Framework
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A theoretical framework which concentrates on political ideology and policy formulation
was selected to promote a legislative analysis and advocacy design. Originally introduced in
Kingdon’s 1984 published work Agendas, Alternatives and Public Policies, the Multiple Streams
framework provides a means of understanding public policy and agenda setting by examination
of historical processes in the United States’ political system (Kingdon, 2003). The framework
identifies three categories of variables which work both independently and interpedently to
determine agenda setting and policy advancement. These categories (deemed “streams” by the
author) are further delineated as the problem, political, and policy streams (illustrated in Figure
2). The confluence of these streams interacts to produce “windows of opportunity” for legislative
action (Kingdon, 2003). The Multiple Streams framework was utilized in this project to conduct
the following legislative analysis, which involved the evaluation of each framework variable in
the context of the KY policy arena. Through analysis, it was determined that timing, value
acceptability, administration changes, and lobbyist involvement may be the largest weighted
factors in future EPT integration for the state of KY. Additionally, barriers to past proposal
attempts were identified along with possible facilitators to future agenda advancement. This was
done in order to fully assess the current climate of KY legislature and to determine a direction of
action for advocacy efforts.
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Figure 2. John Kingdon’s Multiple Streams framework
Problem Stream
The problem stream contains all variables which determine how and when legislators and
policy makers learn about adverse conditions and how such conditions become defined as a
political problem (Kingdon, 2003). While adverse conditions are abundant in everyday life, they
only become political problems when people believe they should take action to change them.
Establishment of a political problem is the first step in promoting practice and policy change.
This is accomplished via the analysis of four problem stream variables: indicators, focusing
events, feedback, and load.
Indicators. Floating at the beginning of the problem stream are indicators, which are
used to assess the magnitude and status of a condition. Large magnitude and deteriorating status
of a condition helps to establish it as a political problem to both officials and the public
(Kingdon, 2003). In the health policy realm, indicators include prevalence, incidence, and
healthcare cost. STI prevalence and incidence have consistently increased in the U.S. over the
past decade. This national incline is mirrored in the state of KY, where the incidence rate of
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chlamydia has more than doubled in the last 10 years (CDC, 2017). The prevalence and
transmission of STIs carry a heavy economic burden. According to a CDC-sponsored study, the
total lifetime direct medical cost of the 19.7 million STI cases in 2008 was $15.6 billion (OwusuEdusei et al., 2013). Among non-viral STIs, Chlamydia was the costliest infection at $516.7
million, followed by Gonorrhea at $162.1 million (Owusu-Edusei et al., 2013). These estimates
do not include indirect costs (e.g., loss of productivity) or intangible costs (e.g., pain, suffering,
and infertility) associated with many STIs. These statistics serve as indicators that STIs are a
major problem in the state of KY, and the increasing incidence in the last year is a marker for
negative status change.
Focusing events. Disasters, crises, personal experiences, or powerful symbols are termed
as focusing events along the problem stream. While indicators may establish a political problem,
the data themselves are not always self-evident enough to launch an agenda campaign. Focusing
events become an extra push that brings an issue to the attention of policy makers, while a lack
of crisis may leave potential agenda items overlooked (Kingdon, 2003). Often times, a personal
experience or story becomes the face of a policy campaign in efforts to humanize an agenda and
make it memorable to legislators and the public. While indicators show that STI transmission
affects many people, the general stigma and privacy associated with diagnosis becomes a barrier
in finding a personal experience to represent a campaign.
Lack of a perceived disaster or crisis can also be considered a factor in the delay to EPT
policy formulation in KY. However, public health crises for STI transmission are looming on the
horizon for the US and KY alike. These crises are expected to develop due to increasing bacterial
resistance and inadequate coverage of current antibiotic regimens. Antibiotic resistance is
already a concern for gonorrheal infections, and care standards now recommend dual therapy of
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ceftriaxone injection plus oral antibiotic therapy to ensure cure (CDC, 2015). According to
providers at the Louisville Specialty Clinic, a branch of the Louisville Metro Department of
Public Health & Wellness which focuses on STI screening and treatment, cases of resistant
trichomoniasis are also emerging. These clinicians attribute increasing bacterial resistance to two
factors: failure to complete antibiotic therapy and reinfection (V. Hughes, personal
communication, September 27, 2018). Reinfection most commonly occurs when a treated patient
continues to have sexual relations with a partner who has not received antibiotics. While the
indicators clearly show a problem in STI transmission and bacterial resistance alike, no crises or
“epidemics” have been publicized to create a focusing event for legislative action in KY.
Feedback. Another variable afloat in the problem stream is feedback, which refers to the
way a problem or promoted policy change is brought to the attention of decisionmakers.
Feedback can be formal or informal. Routine monitoring of costs through budgeting and
government-sponsored program studies is considered formal feedback. In contrast, informal
feedback is provided to a legislator by their constituents in the form of streams of complaints
about a condition, or support or opposition of a specific bill being proposed. Chlamydia and
gonorrhea cases are mandated to be reported to the state department of public health for
epidemiologic and budgeting purposes (CDC, 2006). However, this formal reporting is subject to
review in the public health domain and it is not regularly addressed in the legislative realm.
Informal feedback in regard to STI transmission has also not been consistently presented to
policy makers. While there is no available research to indicate a reasoning behind the lack of
citizen feedback, one could hypothesize that this is due to the sensitive nature and social stigma
that come with transmission of these infections. Additionally, patients may not be aware to lobby
for additional treatment strategies unless they are educated by their providers on these practices.
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Providers must be advocates for their patients in providing feedback to officials and advancing
health policy.
Load. The problem load must be considered when presenting an issue to the policy
agenda. Even though indicators may point to a problem, legislators may be inundated with topics
to tackle in any given session. In KY, annual legislative sessions vary in length depending on the
year. Even years contain a full 60 legislative days, whereas odd years are “short sessions” and
only have 30 legislative days. Odd years (such as this most recent 2019 session) often experience
an increased problem load due to lack of legislative time. Consequently, a specific issue may fall
in priority or the topic may get left off the agenda entirely.
Lobbyists have increased campaign success if they accommodate their ideas to the
current problem load. The KY Department of Public Health (DPH) released the Kentucky State
Health Improvement Plan 2017-2022, which outlines what the department considers the most
pressing issues for the state during the next five years. This improvement plan uses a health
equity framework to highlight substance abuse disorder, smoking, obesity, adverse childhood
experiences, and integration to health access. Integration to health access is defined by this team
as ensuring “all Kentuckians have access to integrated medical, dental, behavioral, and social
services to improve and maintain their health through the development of coordinated, multidisciplinary systems of care” (KY DPH, 2017, p. 53). Healthcare access is specifically linked to
infectious disease in the health equity framework. Using this definition, EPT aligns with KY’s
current aims for health promotion by targeting exposure to infectious disease and halting the
transmission process. EPT should be presented to KY legislation as a policy that aligns with the
current health improvement plan for the state. Accommodating EPT into the current problem
load can provide focus in legislature for this particular issue to increase priority in action.
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Political Stream
The political stream is a separate entity running alongside the problem stream. It contains
all variables to be considered in measuring legislative support for an agenda, which is a major
factor in determining the potential success of a policy. The variables addressed in this branch
include the national mood, organized political forces, and administration changes. These move
from public to governmental factors, and encompass pressure group forces, electoral, and
partisan influences. Public policy is intertwined with political events as shifts of key players (i.e.
new legislators and cabinet, board, and team members) influence agenda setting.
National mood. While some variables in the political stream are tangible in government
schematics, the national mood is a less concrete force subtly directing the policy agenda.
Kingdon describes this mood as a national climate subject to broad social movements and
general changes in public opinion (2003). The national mood directs what the public may or may
not prioritize, be concerned about, or work to address. Themes in this variable can be apparent in
media and social avenues. However, public opinion is often labile depending on the current
societal events and conditions. Legislators’ perception of the national climate can serve either as
a propelling or constraining force in agenda topics. The lack of a public campaign for decreasing
STI transmission has served as a constraining force for EPT treatment legislation. The overall
mood will need to be favorable toward public health, sexual health, and EPT in order for a
regulation amendment to be successful in the state.
Organized political forces. Governmental agendas can be defined as general or
specialized. General agendas usually refer to those promoted by the president to purse a broad
national direction. Specialized agendas are often driven by special interest groups, including
lobbyists, dedicated government departments, and boards or committees of experts. In the
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political stream, mobilization of health-related agendas is often driven by specialized organized
forces. These organizations must perceive a benefit for their respective platforms in order to be
influential advocates. The ODPHP and KY DPH can both be considered dedicated departments
to public health and disease prevention. However, the concept of jurisdiction is important to
consider in targeting useful political forces for KY health policy advancement. While the
ODPHP highlights EPT as a strategy in achieving “timely treatment” for partners, their national
jurisdiction limits the influence in individual state legislation (2017, para. 10). The KY DPH is a
driving force for health policy advancement for the state. Along with aligning agenda items with
current DPH goals, as was done when considering the problem load, gaining support from
individual leaders in this department may open policy advancement opportunities.
Lobbyist groups are also major influencers of the policy agenda. These groups are often
formulated from professionals and experts in a field who collaborate under an organizational
mantel to promote their ideas to legislators. Lobbyists play a large role in education and
campaign organization, providing a united front for a body of individuals and attaching a face
and name to many policy advancement propositions. The KY Board of Medicine (KBM) and KY
Board of Nursing (KBN) can be considered two organized political forces that influence
healthcare in KY. The Kentucky Association for Nurse Practitioners and Nurse-Midwives
(KANPNM) is another prominent lobbyist group in the state’s health policy arena. The
association’s mission is to “empower KY Advanced Practice Registered Nurses in providing
quality, accessible and compassionate healthcare through education, leadership and advocacy”
(KANPNM, 2018, para. 1). This group acts a political force in KY by advocating for policy
advancements in clinical practice change, patient care, and diagnostic and prescribing rights for
Advanced Practice Registered Nurses (APRNs). Dr. Beth Partin, the Legislative Committee

EPT AND KY HEALTH POLICY ADVANCEMENT

19

Chair for the KANPNM, was consulted to determine the coalition’s current capacity to promote
EPT regulation for the 2019 legislative session. The KANPNM spent the majority of its 2019
legislative energy on advocating increased prescriptive authority for APRNs and was unable to
take on EPT as an issue during this year’s session. However, Dr. Partin indicated that the
addition of EPT as a KANPNM agenda item would be feasible in the future if a legislator
sponsor were to be found (personal communication, August 8, 2018). As a voice in the state
legislative arena, the KANPNM was a target group in this project for increasing provider and
lobbyist awareness and support of EPT policy in KY.
Administration changes. The last variable in the political stream is administration
changes. These changes occur due to term limits, elections, and the balance of partisan
majorities. Turnover of key personnel brings agenda and goal changes according to the priorities
and values of the new incumbents. Election terms apply to members of the House of
Representatives and the Senate. Representatives serve two-year terms and are considered for
reelection every even year. Senators hold six-year terms and elections are staggered so that only
about one-third of the Senate is up for reelection during any given year. However, neither
representatives nor senators are subject to term limits, meaning that each member may serve an
unlimited number of terms as long as they are reelected to the position. Representatives are most
directly responsible for presenting new health policy to the state house for approval and a
sponsor is needed for committee formulation and bill proposal. An eventual 2/5th approval by the
members of the chamber is needed for bill approval. If a bill passes one chamber it is then sent to
the other for approval, and both bodies must agree on the final form for it to become a state
statue or regulation.
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While administration changes provoke new topics of discussion, they may make
deserving items impossible to consider. In both 2014 and 2015, regulation amendment legalizing
EPT was proposed to the KY House of Representatives by Representative Mary Lou Marizan.
As a former registered nurse, Rep. Marzian (D) has served as an advocate for public health
policy in the KY House. However, both attempts at proposing an EPT regulation did not pass to
final vote. Legislature influence should be considered in this failure, as these bills were cast to a
predominantly republican House with a socially conservative and fiscal agenda. As a political
stream variable, administration changes play one of the largest roles in determining policy
success and failure, and it is likely that partisan influences had a negative impact on the success
of these bills. Today, administration party ratios remain a factor to consider in policy
advancement as the current voting majority in the KY House has been retained by Republican
constituents, with a 61% (R) / 39% (D) voting share. Consequently, the climate of both the state
House and Senate becomes integral in the proposal and success of EPT policy.
Policy Stream
The final stream in this framework is the policy stream. Kingdon describes the policy
stream as both a flow of “natural selection” and a relative “primeval soup” where ideas swirl and
circulate in policy communities until action is attached to them (2003, p. 116-117). Communities
in this sense describe the collection of specialists and experts in a given policy arena. Ideas in
this stream follow a seemingly erratic path in their progression towards action. Some become
prominent for a time and then fade as other ideas take their place. Other times, an idea will
evolve as it meshes with another concept and combines in various ways. Kingdon acknowledges
a generally long process of “softening up” the public and legislature before an agenda gains
momentum towards policy change (2003). In this softening stage, ideas must be floated,
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proposals drafted, and then amendments made in a response to public or legislator reactions.
Furthermore, in order for this “soup of ideas” to evolve into a tangible policy agenda,
communities must consider three separate policy stream factors: timing for exploitation,
technical feasibility, and value acceptability.
Timing for exploitation. As ideas stir in the policy stream, timing becomes an integral
factor attributing to a proposal’s success or failure. As previously discussed, factors in both the
problem stream and the political stream influence the way issues are perceived and prioritized in
the policy agenda. While problems may exist in a community, timing affects the order in which
they are addressed. Often, lobbyists and policy makers must play a waiting game for an opening
in the political realm where they can insert their proposal. Optimal policy timing balances a
trade-off between delaying reforms and implementing immediate action plans. Using this costbenefit approach, policy makers weigh the potential social or health burden of delaying policy
versus the risk of failure which can occur with immediate action but poor political timing.
Benefits to delaying agendas include additional time to collect better data, as well as the
possibility of capturing a more receptive audience due to national climate changes. Though a
policy may be structurally sound, if the timing does not allow adequate attention and support to
be garnered, it will fail to pass through legislation. Kingdon addresses the importance of
preparation in the policy stream, emphasizing that a “proposal must be worked out beforehand,
and must surface and be pushed when the window is open” (2003, p. 172). Timing for
exploitation can be seen as barrier for past EPT implementation attempts. However, having prior
preparation for EPT legislation in KY is a facilitator for future policy development. The KY
House of Representatives will begin a new session in January of 2020. As new committees and
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agendas emerge in this session, opportune timing will be necessary to bring EPT back to the
forefront of legislation.
Technical feasibility. The second variable along the policy stream addresses technical
feasibility of reform, including policy formulation, campaign efforts, and clinical
implementation. The problem load for both legislation and lobbyist forces becomes an
interdependent factor in assessing technical feasibility. Lobbyists achieve more success when
focusing on one or two issues at a time depending on the workload necessary to drive political
change. This workload differs depending on whether a specific agenda requires a statue or a
regulation change. Both statutes and regulations have the force of law. The term “statute” refers
to a law enacted by a legislative body of a government, whether at the federal or state level.
Statutes are generally broad in their scope and provide a framework for more specific
regulations. Regulations are created by governmental agencies, often to actually implement a
given statue. Most regulations are developed through a process which includes public input,
allowing citizens to influence and shape their laws directly. In general, regulations are easier to
amend than statutes because they often require a simple amendment to update practice instead of
a statutory repeal (Mason, Gardner, Outlaw, & Grady, 2016). In the case of EPT, the prohibitory
law in KY is a DPH regulation, which should facilitate an easier process of amendment.
Clinical implementation is also a consideration as EPT is brought to the agenda. Policy
makers want to ensure that a program will work in application before it is approved.
Implementation of EPT in the clinical setting has been researched in states where the practice is
utilized. While prohibitory legal status has been noted as a barrier, studies have correlated formal
written policy permitting EPT as an effective implementation strategy associated with a higher
rate of provider use (Hodge et al., 2008; Schillinger et al., 2016). Additionally, EPT has been
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linked to lower societal and health care costs as compared to the standard treatment of patient or
provider-based referral (Gift et al., 2011; Hopson & Opiola McCauley, 2017). These findings
indicate the therapy as a clinically feasible and cost-effective option for provider use.
Technical feasibility has also been demonstrated by the number of states which have
adopted EPT policy into regulation since CDC endorsement in 2006. As of 2018, policy
expressly permitting EPT use has been successfully developed and implemented in 42 states and
the District of Columbia. Six other states have repealed legal barriers to implementing EPT but
have not yet explicitly defined the practice in their state regulations (CDC, 2018b). To aid in the
adoption EPT state health policies, Arizona State University (2011) partnered with the CDC in
publishing a toolkit to educate on legislative language, liability issues, and considerations for
drafting legislation and regulations. This model kit serves to enhance technically feasibility in
legislative adoption of EPT policy.
Value acceptability. Value acceptability transcends standard liberal-conservative
dimensions and incorporates the concepts of equity, efficacy, and moral ideology. Tailoring a
proposal to meet an audience’s values greatly affects the reception of the idea. While focusing on
scientific data such as epidemiology and public health benefits may enhance EPT’s appeal in the
community of medical professionals, this strategy is less likely to leave a lasting impression on
legislators and policy makers. Highlighting values of cost reduction and state health
improvement may produce better results in the legislative arena. Value acceptability takes on a
slightly different interpretation when considering EPT in the public eye due to the differing
moral ideologies that are held surrounding sexual behavior and sexually transmitted disease. As a
whole, open discussion surrounding sexual practices has remained taboo in modern society
which hinders public understanding and sense of urgency in addressing the STI crisis. In
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consideration of the impact value acceptability takes on policy advancement, this project aimed
to increase education and facilitate frank and comprehensive dialogue about the STI crisis,
sexual health, and treatment strategies to state legislators.
Policy Window
As variables in the agenda setting streams move forward toward policy formulation, a
window of opportunity is opened. While the problem, political, and policy stream run separately,
they intertwine and couple at critical times to provide opportunity for change. This opening
allows for policy advocates to bring attention to their problem and push their ideas and solutions
toward written regulation. Policy windows open only occasionally and the timeframe in which
they stay open may be quite brief. Policy entrepreneurs and advocates promoting specific
agendas must act rapidly before the opportunity passes by. Otherwise, they may have to wait on
their solutions until the next window comes along. In some instances, the window opens in a
predictable fashion, as when a meeting is scheduled for annual revision of a policy. However, the
policy window is not quite as easily projected in the case of EPT. Due to this unpredictability,
Kingdon writes that it is important to policy entrepreneurs to be prepared, with their problem
well-documented and their proposed solution ready in waiting for the opportune window to
advance their agenda (2003, p. 165). As EPT advocates await a window of opportunity for
regulation amendment in KY, foundational interventions were selected to increase knowledge of
EPT and support for policy and practice change in order to improve chances for future legislative
success.
Setting and Organizational Assessment
With a mix of provider and lobbyist influence in the state legislative arena, the
KANPNM was selected as the main audience for interventions which addressed providers. This
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association is composed of approximately 2,000 KY APRNs and graduate nursing students.
Additionally, ten legislators were selected as target contacts for legislature awareness
interventions. Known barriers to change for both lobbyist and political audiences include heavy
problem load, as many state healthcare concerns are continually being brought to the attention of
policy makers and advocates. Additional known barriers to change for legislator audiences
include value acceptability and perception of technical feasibility in the integration of EPT into
state regulation.
Intervention
This project was composed of four grassroots EPT advocacy interventions. A logic model
was formulated to demonstrate project advocacy activities and consequent goals (Appendix B).
The first intervention, targeted towards providers and lobbyists, included a poster presentation
titled “Expedited Partner Therapy for Treatment of STIs: Advancing Health Policy in
Kentucky”. This literature review poster was presented by the project lead at the annual
KANPNM conference in Lexington, KY in April 2018. The poster educated KY APRNs and
association lobbyists on EPT and current legality, as well as provider use, knowledge, and
facilitators for implementation in states where it is allowable (CDC, 2018c). This was done as a
foundation for further advocacy efforts through the KANPNM.
The second intervention was the authoring and distribution of a white paper, which
stemmed from the CDC 2015 sexually transmitted diseases treatment guidelines, and highlighted
EPT efficacy, implementation, and policy advancement. The formulation of this document
utilized the problem stream variables of indicators and focusing events to demonstrate the need
for policy change while aiming to increase value acceptability to readers. The white paper was
distributed through email to APRNs and by mail to select legislators. The third intervention was
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survey administration and collection from APRNs to measure participation, EPT knowledge, and
intent to support. This project was submitted to the university Institutional Review Board prior to
implementation and was deemed exempt from full review as it did not meet research criteria.
The fourth intervention was legislator contact to increase EPT awareness and support.
Legislator participants were selected by the project lead and recruited through mailed white
paper submission along with follow-up email and phone contact attempts. Six KY House
Representatives and four KY Senators were chosen due to their projected receptivity to health
policy advancement as well as their region of influence. Legislators from the counties with the
top three chlamydia incidence rates were selected: Union, Jefferson, and Fayette (CDC, 2017).
Legislators were active members of their respective chambers to be included. Seven legislators
were able to be contacted via phone call or email. These contacts indicated agreement that STI
transmission is a concerning problem in KY and should be a priority topic for the state to tackle
in upcoming legislative sessions. Six of the contacts stated they were unaware of EPT practice
and indications prior to project education efforts, including its current illegal status in KY. All
seven contacted legislators indicated that they would support EPT legislation and its integration
should it be introduced as a bill in upcoming sessions.
APRN Survey Administration and Results
Participants. Participants included KANPNM members and KY legislators. For poster
presentation, participants were KANPNM conference attendees. For survey collection,
KANPNM members were invited to complete an anonymous survey through an email invitation
with preamble consent prior to survey access. Clicking “proceed” after preamble review
indicated informed consent for participation. All participants were members of the KANPNM to
meet inclusion criteria. Members who were graduate students and those APRNs not currently

EPT AND KY HEALTH POLICY ADVANCEMENT

27

practicing (in education and administrative roles) also met inclusion criteria due to their
stakeholder status.
Data Collection. Data was collected through responses to a secure, encrypted
Surveymonkey account. The link to this survey was administered through an approved
KANPNM listserv, ensuring all participants were eligible for inclusion. Ethical considerations
included value acceptability and current practice strategies among participants. Questions were
structured to be inclusive and avoid ethical dilemmas, allowing participants to skip questions,
answer “not applicable” in demographic variables, and “neither agree nor disagree” in agreement
variables when applicable. Responses were anonymous and no identifiers were collected.
Surveys were downloaded from a secure server and stored on an encrypted computer as well as a
password protected USB drive.
Measurement. Project impact was assessed through KANPNM member survey
responses. Demographic variables were collected, including education level, years of experience,
and current practice status in KY and with patients diagnosed with STIs. Participants were also
asked to answer a six question, five-point Likert scale assessment. This scale was selected due to
its validity in quantifying and measuring agreement indicators. Questions measured perception of
EPT knowledge, satisfaction with standard practice, EPT efficacy, and likelihood in partnering
for future advocacy efforts.
Results. Results of the APRN survey were evaluated using descriptive statistics. A total
of 80 (n = 80) participants responded to survey invitation. No responses were excluded.
Demographic variables indicated a mix of provider experience, education, and current practice
status (see Table 1). 71.25% of respondents were currently practicing in KY. Years of experience
varied, with most respondents falling into either the “1-5 years” or the “15+ years” categories
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(illustrated in Figure 3). 83.5% (n = 66) of participants held a master’s or doctoral degree in
nursing. 65.34% (n = 51) of participants indicated that they practiced in a setting where they
encounter patients for STI diagnosis and treatment.

Figure 3. Respondent years of experience with corresponding distribution
One participant completed only demographic variables, and therefore Likert-scale
questions were evaluated out of the 79 respondents who completed the survey (illustrated in
Figure 4). Agreement variables were assigned the following numerical values for statistical
analysis: Strongly disagree (1), Disagree (2), Neither Agree nor Disagree (3), Agree (4), and
Strongly Agree (5). Both “Agree” and “Strongly Agree” were considered positive responses.
Responses reflected overall satisfactory perceived knowledge, with 73.41% (range 1-5, mean:
3.65, SD: 1) of respondents indicating that they felt knowledgeable of EPT and its indications.
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KANPNM Member Responses regarding Expedited Partner Therapy in KY
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Figure 4. KANPNM member responses regarding Expedited Partner Therapy in Kentucky
Results also demonstrated provider acknowledgement of practice change need for
partners of STI-diagnosed patients. While 51.9% of providers indicated agreement that current
practice strategies for STI prevention and treatment were adequate for their patients, 64.55%
disagreed or strongly disagreed that these same strategies were adequate for partners. The results
also reflected strong positivity toward EPT and future policy advancement in KY. 92.4% (range
3-5, mean 4:53, SD: 0.63) of surveyed providers either agreed or strongly agreed that EPT is a
beneficial treatment strategy for patients and partners. 82.7% (range 2-5, mean: 4.38, SD: 0.86)
of surveyed providers indicated that they would utilize EPT in their clinical practice if it were
legalized. Finally, 93.7% (range 2-5, mean: 4.61, SD: 0.68) of surveyed providers indicated they
would support EPT policy advancement in KY.
Policy Analysis Outcomes and Discussion
Results from policy analysis and advocacy efforts were measured through qualitative
evaluation of verbal feedback from providers and legislators. The poster presentation received
positive responses from conference attendees in increasing APRN knowledge of EPT, legal
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status in KY, and indication for state regulation amendment. Many APRNs stated that prior to
project intervention, though they were aware of the high STI incidence rates in the state, they
were not fully knowledgeable on EPT practice or the significant impact of state regulation on
provider strategies for STI treatment. These providers indicated they would increase their
advocacy for future EPT legislation due to project impact. Through follow-up contact with target
legislators after white paper distribution, feedback was collected from seven representatives and
senators who all reported favorability toward future EPT advancement in KY. Five legislators
were unaware of the high STI incidence rates in the state, and reported they were not
knowledgeable about updated CDC guidelines, EPT practice, and STI state regulation prior to
education through project interventions. All contacted legislators indicated that increased
knowledge of high STI incidence and transmission, as well as the impact of state regulation on
STI treatment options was influential in increasing legislative support of policy amendment. All
contacted representatives agreed that increased lobbyist and stakeholder advocacy is crucial for
amendment success and stated they would support the future integration EPT into state health
policy.
Interpretation
Policy advancement requires a balance of many variables; initial legislative analysis
found that timing, value acceptability, administration changes, and lobbyist involvement may be
the largest weighted factors in future EPT integration for the state of KY. Responses from
legislators reflected favorability towards the future integration of EPT in KY state regulation,
which is a vital component in policy change. A sponsoring legislator will need to be secured for
bill proposal and future advocates may consider approaching one of the legislators who were
amenable to such policy change through this project.
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Survey results reflect that KY APRNs acknowledge the need for updated STI state policy
and indicate support for the advancement of EPT. As stakeholder support is one of the most
crucial aspects of agenda success, this project accomplished its goal in advocating for EPT by
increasing provider and lobbyist support. However, APRNs are not the only stakeholders in the
healthy policy realm and other specialties such as medical doctors, pharmacists, and public
health workers should be consulted and targeted for advocacy interventions. Future advocates
may consider advancing interventions to lobbyist groups such as the KY Board of Nursing, KY
Board of Medicine, and KY Department of Public Health.
An incidental finding in this project during verbal feedback indicated that many KY
providers are currently utilizing EPT in clinical practice without knowledge that it is prohibited
in the state. This may be to provider migration from other regions, as EPT is taught and regularly
implemented in most other states in the country. This finding indicates a need for increased
education to providers on EPT practice and its current regulatory status in KY.
Limitations
Several limitations were encountered during project implementation. Survey results were
limited by small sample size and low response rate. Additionally, due to project scope,
participants were restricted to those in the nursing field. Increased interdisciplinary sponsorship
through all healthcare roles will be necessary to dramatically improve the chance of amendment
success. Generalizable assessment of legislator support was limited due to small sample size and
similar partisanship of contacts. Partisan influences have limited EPT advancement in past
attempts and may become apparent in the future if a bill were to be sponsored.
Progression of a bill for regulation amendment was limited during project
implementation due to several factors. Firstly, the 2019 KY legislative session was “short”,
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consisting of only 30 legislative days instead of a full 60 (occurring on even-numbered years).
This resulted in an increased problem load for lobbyists and legislators as other pressing matters
for KY state health took precedence over STI transmission. While STI incidence continues to
increase in KY, the lack of a focusing event such as major STI crisis or perceived epidemic
continues to be a limitation in policy advancement. Treatment failure due to uncontrolled
transmission and antibiotic resistance may serve as a future focusing event to move EPT policy
forward in the state. Additionally, this shorter legislative session limited long-term follow up
with legislative contacts which may have facilitated agenda advancement. KANPNM lobbyist
efforts for EPT were restricted due to simultaneous needs for advocacy efforts in APRN
prescribing authority. An overarching limitation to all policy advancement stems from the multifactorial political arena, where advocates must work to balance ever-changing variables in the
Multiple Streams Framework in order to best predict the opening of a Policy Window.
Conclusion
EPT is an evidence-based approach which increases treatment and adherence for partners
with patients diagnosed with STIs. The lack of DPH regulation amendment supporting EPT in
KY limits provider options in caring for patients diagnosed with certain STIs. The practice of
EPT could be a benefit to many patients in the commonwealth; especially for those patients who
are high-risk and partners who may not have access to health care or choose not to pursue
physical examination. Therefore, legislation in KY should be updated to include explicit health
policy allowing EPT use according to CDC recommendations and provider discretion as they
collaborate with their patients to formulate safe, efficacious treatment plans.
Both the healthcare and legislative arenas are complex organizations which require
adaptability to ever-changing environments. In order to advocate for EPT policy advancement in
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KY, a four-fold intervention was conducted. APRNs are an ideal target audience for poster and
white paper interventions due to their stakeholder status in KY health policy. APRNs are trained
to be leaders in their healthcare communities and are influential advocates for policy change in
the political arena. APRN participants indicated increased awareness and support of EPT
integration into state policy. Additionally, seven initial legislator contacts were made, and verbal
feedback indicates positive receptivity towards EPT in the future. These responses indicate an
achieved goal for this project’s scope of influence.
State representatives and senators are most directly responsible for presenting new health
policy to the respective House and Senate for approval. A sponsor will be needed for committee
formulation and bill proposal. While the next legislative session will not begin until January
2020, advocates for EPT are needed to raise awareness of STI transmission and therapeutic,
evidence-based practice alternatives to standard practice inadequacies. The 2020 legislative
session will last a full 60 legislative days which may mean more opportunity for bill proposal
and committee delegation towards regulation amendment. Enhancing stakeholder knowledge and
buy-in, appealing to lobbyist groups for platform support, and engaging in personal and
meaningful discussion with legislators will continue to be necessary interventions in integrating
EPT and improving chance of agenda success. Advocates are encouraged to reach out to their
coalition leaders and legislators to stimulate conversation on EPT and the related need for
practice change as policy advocates work towards the opening of a window of opportunity for
STI regulation amendment in KY.
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Appendix A

Hierarchal Table of Evidence
Citation JHNEBP
Level of
Evidence
Trelle et
al., 2007

Level I

Design/ Methods

Measures/
Tools

Data
Analysis

Findings

Quality of Evidence

Systematic review of
RCTs;
intervention as
supplement to standard
patient referral.
Data sources:
7 electronic databases
searched
January 1990 to
December 2005
-Random effects
meta-analysis:
14 trials (N = 12,389)
Subjects with gonorrhea,
chlamydia,
urethritis, trichomoniasis,
EPT specifically: 6,719
(4,912 women, 1807 men)
in 6 RCTs

Use of EPT
through patient
delivered partner
therapy antibiotic
1) reduction of
incidence or
prevalence of
sexually
transmitted
infections
in index patients
2) number of
partners treated;
number of partners
tested or testing
positive; and
number of partners
notified, located, or
elicited.
Measures:
Reinfection rates as
defined by each
infection’s gold
standard of medical
diagnosis (e.g.
nucleic acid
amplification in
chlamydia) for
high tool reliability
and validity

Outcomes
reported as
proportions
were calculated
as exact 95%
confidence
intervals or
two-sided P
values. Random
effects metaanalysis;
heterogeneity
assessed using
Cochran’s Q &
the I2 statistic;
In metaanalyses with at
least 5 trials:
funnel plots &
statistical
testing for small
study effects.

1) Meta-analysis of 5 RCT
linked EPT to reduced risk of
persistent or recurrent
infection in patients with
chlamydia or gonorrhea
(summary RR 0.73, 95%
confidence interval 0.57 to
0.93)
2)supplementing
patient referral with
information for partners also
effective
3) 2 RCTs found providing
index patients with
chlamydia with sampling kits
for their partners
increased # of partners who
got treated
4) increase in
the number of partners treated
(risk ratio 1.44, 95%, CI 1.12
to 1.86), but statistical
heterogeneity high (I2 94%, P
< 0.0001)

Strengths:
Large sample sizes;
subjectivity minimized by
carrying out study
selection,
data extraction, & quality
assessment
Weaknesses: All studies
had
methodological
weaknesses that could
have biased results
(inadequate allocation
concealment); differences
in interventions and
outcomes
limited the use of metaanalysis to summarize
results
and explore heterogeneity
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Golden et
al., 2005

Golden et
al., 2015

Level II

Level II

Randomized-controlled
trial; (N = 931 in EPT
group; control = 929)

Stepped-wedge,
community level
randomized- controlled
trial; four intervention
waves (6-8 mo each)
randomly assigned to
local health jurisdictions
with purpose -To assess
EPT effect as well as
scalability of public
health EPT intervention
(23 jurisdictions; N =
5,741)

Persistent or
recurrent gonorrhea
or chlamydial
infection in
patients 3 to 19
weeks after
treatment using
urine samples for
Chlamydia
trachomatis and,
for those who
originally received
a diagnosis of
gonorrhea, for
Neisseria
gonorrhoeae, using
LCx ligase chain
reaction (Abbott
Diagnostics) or
Aptima Combo 2
(Gen-Probe)

Promotion of EPT
uptake – EPT
packets supplied to
clinics, partnership
with pharmacies,
education to
providers, referral
of high-risk
patients to health
department for
EPT; results
measured through
analysis intervals
of nucleic acid
amplification
chlamydia test
positivity.

39
Two-tailed T
test; Fischer’s
exact test;
Bivariate/
multivariate
relative risks &
associated
confidence
intervals
comparing
partnernotification
outcomes or
infection
outcomes
estimated with a
generalized
linear model
with a binary
outcome and
log link and
robust standard
errors
-Mixed effects
generalized
linear model
-2-tailed test
-single post hoc
assessment
-Poststratification
weights used to
adjust for
nonresponse
bias

GC/CL infection significantly
less common at follow-up
among patients in EPT group
than in standard-referral group
(RR, 0.76; 95% CI, 0.59 to
0.98). EPT of partners
associated with a 73%
reduction in presence of GC (3
% vs. 11%, P=0.01), but only
a 15% reduction in presence of
CL infection at follow-up
(11% vs. 13%, P=0.17).

Strengths:
Large sample size
meeting power;
randomization, high tool
reliability and validity

1) EPT acceptance increase
from 18.3% pre-intervention
to 43.9% during intervention
(p < 0.001)
2) 92.6% patients receiving
EPT reported compliance
3) Chlamydia positivity
decrease from 8.2% to 6.5% (p
< 0.0001). Post hoc RR
associated w/ 10% decrease in
population-level infection
measures.

Strengths: large sample
size, adequate power;
RCT design; adequate
time frame for evaluation
of trends

Weaknesses: loss to
follow-up may affect
internal validity

Weaknesses: inability to
evaluate effect of state
law changes mid-study
increasing funding for
EPT (possible
confounding factor);
inability to ensure no
mixing of individuals in
specific LHJ sample
groups.
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OwusuEdusei Jr.
et al.,
2017

Level III

Longitudinal study; 51
state-level monthly
morbidity rates (including
D.C.) from national
surveillance data with
autoregressive time series
model analysis; mixed
model approach with
analysis of fixed effects
and random effects;
(N= 26 states with EPT
policies;
Control = 25 states
which lack EPT laws)

Hsii et al.,
2012

Level III

Cross-sectional study;
anonymous online survey;
289 responses from
pediatric residents in 14
California programs (78%

Reported as highly
reliable though
validity not
discussed.
Additional goals of
EPT uptake
measured through
random sampling
interview of
patients regarding
availability and
acceptance/refusal.
Monthly state-level
gonorrhea
morbidity rates for
males and females
Jan 1995-Dec
2014, no age
restrictions;
Autoregressive
time series model,
panel approach
(higher variability
& degrees of
freedom with
minimal multicollinearity
concerns); highly
valid approach but
reliability not
discussed
explicitly. National
surveillance data
collected from
provider report.
57-item
questionnaire to
assess current
knowledge, clinical
practices, and
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Transformation
of data to
natural logs
(variance
stabilization);
Fisher-type unit
root test with
Dickey-Fuller
option

1) monthly variance in
gonorrhea morbidity (both
increasing/decreasing) existent
in all states regardless of EPT
laws
2) fixed effects model
showing 4 states had
significant instant decrease of
infection after EPT law (p <
0.01) but 2 states had
significant increase (p < 0.01)
3) random effects model
showing no significant
differences in groups

Strengths: large sample
size; length of assessment
adequate to monitor for
trends; clear set-up for
further research
Weaknesses: study
assessed only gonorrhea
rates, limited by
increasing resistance of
bacteria through study
period; limitation
regarding surveillance
data due to reliance on
provider report of disease
& inability to measure
provider usage of EPT
once legalized as well as
patient adherence to
treatment

X2 analyses for
categorical
variables,
ANOVA for
analysis of PGY

-21% reporting moderate or
very familiar with EPT; 24%
reporting having education on
the practice (85% learned
from direct patient care)

Strengths:
Results consistent with
other studies regarding
perceived barriers,
provider knowledge; high
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female, mean age 29.4 +/2.7 years), postgraduate
years 1,2, and 3 included
with no exclusion criteria

Schillinge
r et al.,
2016

Level V

Systematic review of
published articles, data
reports, and conference
abstracts providing
measures of 1) provider
uptake of EPT
2) patient delivery of EPT
3) partner receipt of EPT
and treatment; 42
literature sources meeting
inclusion criteria

personal comfort
using EPT. Closed
response questions.
Combination of
forced-choice
questions and 4point Likert scales
used for high tool
reliability and
validity

Measures:
“Provider uptake”
defined as
proportion of
providers
supporting EPT use
in qualitative
terms; “offer
percentages”
defined as
proportion of EPTeligible patients
who are offered
EPT from a
practicing provider;
“Patient
acceptance”
defined as
proportion of
patients accepting
EPT when it is
offered; “Partner
receipt” defined as
proportion of
patients who had at
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groups,
Kruskal-Wallis
test for ordinal
variables;
analysis by
presences of
adolescent
fellowship: ttest for
continuous
variables and
Wilcoxon ranksum test for
ordinal
variables.
Data abstraction
with
representation
of each study in
alphabetical
order in
structured table
format (7
tables), one for
each measure
and additional
interventions
for enhancing
EPT use
-Many differing
statistical
measures used
for included
studies

-inadequate understanding of
EPT methods
-52% reported using 1 type of
EPT in practice, but 74%
using EPT only “rarely” or
“sometimes”
-inadequate knowledge of
clinical and state policy
regarding EPT
- perceived barriers including
concern of adverse drug event,
adherence, counselling, &
unfamiliarity with policy

participation with good
distribution of PGY
groups

1) 11 articles reporting percent
of providers using EPT (range
14%-73% for routine use)
2) provider offer rate low
(27% to 31%) as found in 3
studies
3) 3 sources reporting patient
acceptance (38% to 70%)
4) patient deliverance rate
from 73%-100 from 4
literature sources

Strengths:
Heterogeneous mix of
study designs from RCTs
to qualitative, good
amount of data reviewed,
description of measures
discussed, conceptual
framework established
Weaknesses:
Unpublished data used in
attempt to collect most
up-to-date data but
weakens reliability of
sources, variance of
results for certain
measures is high

Weaknesses:
Possible
recall/selection/responder
biases due to survey
nature of study design
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Hodge et
al., 2008

Level V

Qualitative descriptive
study; identify legal
provisions that affect a
clinician’s ability to
provide EPT through
review of 3 areas of legal
relevance: 1) medical
licensing and liability
2) public health and
safety. 3) pharmaceutical
practices
-50 states + 2 jurisdiction
-examined statutes, bills,
administrative
regulations, judicial cases
related to primary
objective

least 1 partner
treated by EPT
Measures: -14
defined search
terms
Laws limited to
those addressing,
1) ability of
authorized HCP to
provide patient’s
partner with STD
treatment without
physical exam; 2)
judicial decisions
regarding
discipline for HCPs
using EPT; 3)
administrative
opinions from the
attorney generals,
medical and
pharmacy boards;
4) legislative or
prospective bills
which provide
insight into the
legality of EPT; 5)
laws that
incorporate or
adopt national
guidelines that may
support EPT; and
6) prescription
drug laws
-No discussion of
reliability/validity
of tools
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Due to nature of
study, no
program
statistical
analysis; legal
information
organized by
jurisdiction in a
comprehensive
table and map
presenting
summaries of
relevant law
and ruling
concerning EPT

1) 12 jurisdictions where EPT
is legal, 13 in which EPT is
“probably legally prohibited”,
and 28 where EPT is
potentially allowable
2) in those where EPT legality
is uncertain, inconsistent or
ambiguous laws may cause
providers to hesitate use of
this therapy (call for more
explicit and direct legislation)
3) CDC guidelines may
effectively endorse EPT unless
trumped by contrary statutory
provision
4) 88% boards perceive EPT
as illegal or uncertain legality
(barrier to use)

Strengths:
Establishing important
parties in EPT
legalization, no exclusion
of states, per-reviewed,
wide-range of inclusive
and relevant search terms
Weakness: due to article
age and topic, some
results from study may be
outdated, no specific
theoretical framework, no
discussion of
reliability/validity of tools
used for measures, no
statistical significance
discussed due to nature of
study
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Appendix B
Logic Model for Project Implementation
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Table 1
KANPNM Member Demographics
KANPNM Member Demographics
n = 80 KANPNM Members
(APRNs/graduate students)
Demographic Variable
n (%)
Currently a KY Provider?
Yes
57 (71.25)
No
23 (28.75)
Years of Experience:
<1 year
7 (8.75)
1-5 years
23 (28.75)
6-10 years
9 (11.25)
11-15 years
8 (10.00)
15+ years
23 (28.75)
N/A (students)
10 (12.50)
Highest Degree Held:
BSN
13 (16.46)
MSN
45 (56.96)
DNP
18 (22.78)
PhD
3 (3.80)
Currently Treating STIs?
Yes
53 (66.25)
No
27 (33.75)
Number of Monthly Patient
Encounters for STI
Screening/Treatment:
1-5
19 (25.00)
6-10
16 (21.05)
11-15
7 (9.21)
15+
8 (10.53)
N/A
26 (34.21)
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Table 2
KANPNM Member Responses regarding EPT in KY
Strongly

Neither

Disagree

Disagree

Agree nor

Agree

Strongly

(1)

(2)

Disagree (3)

(4)

Agree (5)

n (%)

n (%)

n (%)

n (%)

n (%)

Knowledgeable of EPT

2

10

9

42

16

Practice and Indications

(2.53%)

(12.66%)

(11.39%)

(53.16%)

(20.25%)

Current STI Treatment

2

15

21

34

7

is Adequate for Patients

(2.53%)

(18.99%)

(26.58%)

(43.04%)

(8.86%)

Current STI Treatment

18

33

16

9

3

is Adequate for Partners

(22.78%)

(41.77%)

(20.25%)

(11.39%)

(3.80%)

0

0

6

25

48

(0.00%)

(0.00%)

(7.59%)

(31.65%)

(60.76%)

0

3

11

18

47

(0.00%)

(3.80%)

(13.92%)

(22.78%)

(59.49%)

0

2

3

19

55

(0.00%)

(2.53%)

(3.80%)

(24.05%)

(69.62%)

Survey Question

EPT a Beneficial
Strategy for Patients &
Partners
Would use EPT in
Clinical Practice if
Legal
Would Support EPT
Policy Advancement in
KY
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